PHOENIX ATROPINE INJECTION

País: Nueva Zelanda

Idioma: inglés

Fuente: Ministry for Primary Industries

Ingredientes activos:

atropine sulphate

Disponible desde:

Phoenix Pharm Distributors Ltd

Designación común internacional (DCI):

atropine sulphate

Composición:

atropine sulphate 0.65 g/litre

Área terapéutica:

Antidote

Estado de Autorización:

ACVM Registered

Fecha de autorización:

1986-12-22

Ficha técnica

Phoenix Atropine Injection (A5436)
November 2022
Text Label
FOR ANIMAL TREATMENT ONLY
KEEP OUT OF REACH OF CHILDREN
RESTRICTED VETERINARY MEDICINE
PHOENIX ATROPINE INJECTION
ACTIVE INGREDIENT:
ATROPINE SULPHATE
0.65 mg/mL
50 mL net
INDICATIONS:
For preanaesthetic medication and the treatment of organophosphate
poisoning.
READ THE LABEL BEFORE USE.
DOSAGE AND ADMINISTRATION:
Dogs and cats
As a preanaesthetic adjuvant: 0.02 – 0.04 mg/kg by IV, IM or SC
routes.
For treatment of organophosphate poisoning: 0.2 – 2.0 mg/kg to
effect to achieve atropinisation;
give 1/4
th
of the dose by slow IV and the remainder by IM or SC routes. Repeat
every 3-6 hours as
necessary until signs of poisoning are relieved.
STORAGE:
Store below 30°C.
KEEP OUT OF REACH OF CHILDREN
Registered pursuant to the ACVM Act 1997, No. A5436
See www.foodsafety.govt.nz for registration conditions.
Registered to and distributed by:
Phoenix Pharm Distributors Ltd
3C Whetu Place, Rosedale, Auckland
Ph: 0800 10 55 66
Batch No.
Expiry Date